Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-15

Clinical Trial Update: A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB Patients [NA]

View source ↗

Summary

A completed pilot trial evaluated Spincare Matrix, a temporary skin substitute, for wound healing in patients with Recessive Dystrophic Epidermolysis Bullosa (R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spincare Matrix

Snippet

Sponsor: Stanford University | Conditions: Recessive Dystrophic Epidermolysis Bullosa | NA | Status: COMPLETED | Results posted: 2025-09-15